These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.
Scientific report questions effectiveness of Alzheimer's drugs Leqimbi and Kisunla in slowing the disease.
impact+0.30
sentiment-0.20
n=3
a scientific report questioned how much leqimbi and kisunla actually slow alzheimer's. the drugs, which hit the market in the last few years, had been labeled "breakthrough" treatments. the report scrutinizes the evidence behind their ability to delay the disease's progression.
read at marketwatch_top →